Nautilus Biotechnology Inc. (NAUT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Nautilus Biotechnology In...

NASDAQ: NAUT · Real-Time Price · USD
0.83
0.01 (0.96%)
At close: Sep 26, 2025, 3:59 PM
0.82
-0.72%
After-hours: Sep 26, 2025, 05:15 PM EDT

Nautilus Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
27.65M 19.4M 114.52M 185.62M
Short-Term Investments
102.25M 154.02M 69.95M 160.11M
Long-Term Investments
76.41M 90.65M 129.17M 16.37M
Other Long-Term Assets
1.18M 1.18M 1.11M 997K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.93M 3.42M 2.74M n/a
Total Current Assets
132.83M 176.84M 187.21M 349.22M
Property-Plant & Equipment
32.33M 36.9M 32.57M 31.86M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
109.92M 128.73M 162.84M 49.23M
Total Assets
242.74M 305.56M 350.05M 398.45M
Account Payables
987K 1.64M 1.27M 1.72M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 1.99M 970K
Other Current Liabilities
2.55M 2.97M 116K 883K
Total Current Liabilities
7.63M 9.12M 6.79M 5.81M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
26.38M 31.09M 28.34M 29.06M
Total Liabilities
34.01M 40.21M 35.13M 34.87M
Total Debt
30.48M 34.63M 30.33M 30.03M
Book Value
208.73M 265.35M 314.92M 363.58M
Book Value Per Share
1.66 2.12 2.53 4.30
Common Stock
13K 13K 12K 12K
Retained Earnings
-273.02M -202.24M -138.56M -80.64M
Comprehensive Income
57K -255K -1.85M -184K
Shareholders Equity
208.73M 265.35M 314.92M 363.58M
Total Investments
178.65M 244.67M 199.12M 176.48M